F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor Positive|Recurrent Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7
Interventions: PROCEDURE: Computed Tomography|PROCEDURE: Computed Tomography|DRUG: F-18 16 Alpha-Fluoroestradiol|DRUG: Fludeoxyglucose F-18|OTHER: Laboratory Biomarker Analysis|PROCEDURE: Positron Emission Tomography|PROCEDURE: Positron Emission Tomography
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)